A Retrospective Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar Disc Degenerative Disease in China.
Phase of Trial: Phase IV
Latest Information Update: 26 Sep 2012
At a glance
- Drugs Alternative medicine; Mecobalamin; Nonsteroidal anti-inflammatories
- Indications Spinal disorders
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 25 Nov 2011 Actual patients number (478) added as reported by ClinicalTrials.gov.
- 25 May 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 25 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.